“There are a lot of people, particularly in developing countries, that have not had the opportunity to have vaccines,” James Love tells The World’s host Marco Werman. “And so, a treatment like this will really be important.”
The FDA had been making plans to allow TEVA Pharmaceuticals to sell its Plan B contraceptive in front of the pharmacy counter to women of any age. But Health and Human Services Secretary Kathleen Sebelius intervened at the last minute to prevent it.
After 20 years being the only game in town, Pfizer, the manufacturer of Lipitor, is about to get some competition in the space for treating those with chronic high cholesterol. The patent expired Wednesday and one generic drug is ready to hit the market. Others should arrive in six months.